Outcomes After Bilateral Native Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A Contemporary Single-Centre NHS Cohort Study (2018–2024)

Background/Objectives: Bilateral native nephrectomy (BNN) is undertaken selectively in autosomal dominant polycystic kidney disease (ADPKD) to relieve symptoms or to create iliac fossa space for transplantation. Contemporary UK National Health Service outcome data are scarce. We describe indications, morbidity and mortality after open BNN at a UK tertiary transplant centre. Methods: This is a retrospective descriptive cohort study of 34 consecutive adults with ADPKD undergoing open BNN between August 2018 and September 2024, reported per STROBE, without a comparator group. Pre-specified primary outcomes were length of stay (LoS) and Clavien–Dindo (CD) ≥III complications. Exploratory analyses used regression on log(LoS), with a sensitivity analysis excluding one outlier, and Firth-penalised logistic regression. Results: Median age was 55 years (IQR 51–62); 29 patients (85.3%) were dialysis-dependent, and 5 (14.7%) had a functioning allograft. No procedure was concurrent with transplantation. The commonest indication was insufficient space for a kidney graft (21/34, 61.8%). Median LoS was 8 days (IQR 7–10). CD≥III complications occurred in 5/34 (14.7%; 95% CI 6.4–30.1%) and transfusion in 6/34 (17.6%); grade I–II complications were not systematically recorded. There were no in-hospital, 30-day or 90-day deaths. Over a median potential follow-up of 53 months, 15/34 (44.1%) underwent transplantation. Transfusion was associated with longer LoS (β = 0.58; p = 0.035), but not after excluding one outlier (p = 0.348), and was not significantly associated with CD≥III (OR 4.05; 95% CI 0.54–28.4). No invasive malignancy was found in 29 histopathology reports. Conclusions: In this small single-centre series, open BNN was performed mainly to enable transplantation, with no early mortality and a 14.7% CD≥III rate. These descriptive baseline data cannot establish benefit relative to unilateral or no nephrectomy.

Authors

Institutions

Publication Details

Journal
Journal of Clinical Medicine
Published
2026-10-30
DOI
https://doi.org/10.3390/jcm15218456
Primary Topic
Genetic and Kidney Cyst Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Outcomes After Bilateral Native Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A Contemporary Single-Centre NHS Cohort Study (2018–2024)

Frank J. M. F. Dor, Kavyesh Vivek, Nikolaos-Andreas Anastasopoulos, Vassilios E Papalois
3 links
Journal of Clinical Medicine
Genetic and Kidney Cyst Diseases
article

Outcomes After Bilateral Native Nephrectomy in Autosomal Dominant Polycystic Kidney Disease: A Contemporary Single-Centre NHS Cohort Study (2018–2024)

Frank J. M. F. Dor, Kavyesh Vivek, Nikolaos-Andreas Anastasopoulos, Vassilios E Papalois
article en

Abstract

Background/Objectives: Bilateral native nephrectomy (BNN) is undertaken selectively in autosomal dominant polycystic kidney disease (ADPKD) to relieve symptoms or to create iliac fossa space for transplantation. Contemporary UK National Health Service outcome data are scarce. We describe indications, morbidity and mortality after open BNN at a UK tertiary transplant centre. Methods: This is a retrospective descriptive cohort study of 34 consecutive adults with ADPKD undergoing open BNN between August 2018 and September 2024, reported per STROBE, without a comparator group. Pre-specified primary outcomes were length of stay (LoS) and Clavien–Dindo (CD) ≥III complications. Exploratory analyses used regression on log(LoS), with a sensitivity analysis excluding one outlier, and Firth-penalised logistic regression. Results: Median age was 55 years (IQR 51–62); 29 patients (85.3%) were dialysis-dependent, and 5 (14.7%) had a functioning allograft. No procedure was concurrent with transplantation. The commonest indication was insufficient space for a kidney graft (21/34, 61.8%). Median LoS was 8 days (IQR 7–10). CD≥III complications occurred in 5/34 (14.7%; 95% CI 6.4–30.1%) and transfusion in 6/34 (17.6%); grade I–II complications were not systematically recorded. There were no in-hospital, 30-day or 90-day deaths. Over a median potential follow-up of 53 months, 15/34 (44.1%) underwent transplantation. Transfusion was associated with longer LoS (β = 0.58; p = 0.035), but not after excluding one outlier (p = 0.348), and was not significantly associated with CD≥III (OR 4.05; 95% CI 0.54–28.4). No invasive malignancy was found in 29 histopathology reports. Conclusions: In this small single-centre series, open BNN was performed mainly to enable transplantation, with no early mortality and a 14.7% CD≥III rate. These descriptive baseline data cannot establish benefit relative to unilateral or no nephrectomy.

Journal of Clinical MedicineVol. 15(21)
Imperial College Healthcare NHS Trust (GB), Hammersmith Hospital (GB), Imperial College London (GB)
Good health and well-being
Openalex Percentile: Top 15%
Genetic and Kidney Cyst Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon